JPS646191B2 - - Google Patents

Info

Publication number
JPS646191B2
JPS646191B2 JP55143778A JP14377880A JPS646191B2 JP S646191 B2 JPS646191 B2 JP S646191B2 JP 55143778 A JP55143778 A JP 55143778A JP 14377880 A JP14377880 A JP 14377880A JP S646191 B2 JPS646191 B2 JP S646191B2
Authority
JP
Japan
Prior art keywords
group
hydrogen atom
compound
formula
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55143778A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5665869A (en
Inventor
Kinasuto Gyuntaa
Myuraa Ruutsu
Jitsuto Ryuuteigaa
Purusu Barutaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS5665869A publication Critical patent/JPS5665869A/ja
Publication of JPS646191B2 publication Critical patent/JPS646191B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP14377880A 1979-10-19 1980-10-16 Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug Granted JPS5665869A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792942365 DE2942365A1 (de) 1979-10-19 1979-10-19 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP63132885A Division JPH01131156A (ja) 1979-10-19 1988-06-01 ピペリジン誘導体

Publications (2)

Publication Number Publication Date
JPS5665869A JPS5665869A (en) 1981-06-03
JPS646191B2 true JPS646191B2 (en]) 1989-02-02

Family

ID=6083911

Family Applications (2)

Application Number Title Priority Date Filing Date
JP14377880A Granted JPS5665869A (en) 1979-10-19 1980-10-16 Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug
JP63132885A Pending JPH01131156A (ja) 1979-10-19 1988-06-01 ピペリジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP63132885A Pending JPH01131156A (ja) 1979-10-19 1988-06-01 ピペリジン誘導体

Country Status (15)

Country Link
US (1) US4348402A (en])
EP (1) EP0027908B1 (en])
JP (2) JPS5665869A (en])
AT (1) ATE4642T1 (en])
AU (1) AU6319480A (en])
CA (1) CA1161439A (en])
DE (2) DE2942365A1 (en])
DK (1) DK441180A (en])
ES (1) ES8106891A1 (en])
FI (1) FI803264L (en])
GR (1) GR71207B (en])
HU (1) HU181203B (en])
IL (1) IL61285A (en])
NO (1) NO802939L (en])
ZA (1) ZA806399B (en])

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0556770U (ja) * 1991-10-25 1993-07-27 井関農機株式会社 走行クロ−ラにおけるスライド装置

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582758B2 (en) * 1984-06-28 1989-04-13 Mect Corporation Sialic acid derivatives, galactose derivatives and method for producing the same
US4634765A (en) * 1984-12-18 1987-01-06 Merrell Dow Pharmaceuticals Inc. Homodisaccharide hypoglycemic agents
US5231185A (en) * 1985-11-19 1993-07-27 Cornell Research Foundation, Inc. Monosaccharide analog-based glycosidase inhibitors
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
US5003072A (en) * 1988-11-03 1991-03-26 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US5221746A (en) * 1988-11-03 1993-06-22 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US5310745A (en) * 1988-11-03 1994-05-10 G. D. Searle & Co. Antiviral compounds
US5025021A (en) * 1989-07-27 1991-06-18 Monsanto Company 1,2-dideoxy-2-fluoronojirimycin as glycosidase inhibitors
US5175168A (en) * 1989-07-27 1992-12-29 Monsanto Company Intermediates for 1,2-dideoxy-2-fluoronojirimycin
US5026713A (en) * 1989-08-29 1991-06-25 Monsanto Company 1,3-dideoxy-3-fluoronojirimycin which inhibits glycosidase activity
US5130320A (en) * 1989-08-29 1992-07-14 Monsanto Company Glycosidase inhibiting 1,3-dideoxy-3-fluoronojirimycin
US5218121A (en) * 1989-08-29 1993-06-08 Monsanto Company Synthesis of 1,3-dideoxy-3-fluoronojirimycin
WO1999020632A1 (fr) * 1997-10-23 1999-04-29 Takeda Chemical Industries, Ltd. Derives d'imidazopyridine condenses, leur procede de production et preparations les renfermant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
GB1554117A (en) * 1976-12-23 1979-10-17 Bayer Ag Inhibitors for a-glucosidases
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS5470955A (en) * 1977-11-15 1979-06-07 Baasatairu Mfg Ltd Rotary type combine
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
JPS5515365A (en) * 1978-07-20 1980-02-02 Mitsubishi Heavy Ind Ltd Hull remodelling method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0556770U (ja) * 1991-10-25 1993-07-27 井関農機株式会社 走行クロ−ラにおけるスライド装置

Also Published As

Publication number Publication date
GR71207B (en]) 1983-04-11
US4348402A (en) 1982-09-07
DK441180A (da) 1981-04-20
EP0027908B1 (de) 1983-09-14
AU6319480A (en) 1981-04-30
EP0027908A3 (en) 1981-08-05
ATE4642T1 (de) 1983-09-15
DE2942365A1 (de) 1981-05-14
HU181203B (en) 1983-06-28
ZA806399B (en) 1981-10-28
CA1161439A (en) 1984-01-31
DE3064835D1 (en) 1983-10-20
FI803264A7 (fi) 1981-04-20
JPH01131156A (ja) 1989-05-24
JPS5665869A (en) 1981-06-03
ES496038A0 (es) 1981-09-16
IL61285A0 (en) 1980-12-31
IL61285A (en) 1984-10-31
EP0027908A2 (de) 1981-05-06
FI803264L (fi) 1981-04-20
ES8106891A1 (es) 1981-09-16
NO802939L (no) 1981-04-21

Similar Documents

Publication Publication Date Title
JPS646191B2 (en])
EP0028833B1 (en) Imidazole derivatives, their production and use
EP0051023B1 (fr) Nouveaux composés appartenant à la famille des benzoyl- et alpha-hydroxybenzyl-phényl-osides, leur procédé de préparation et leur application en thérapeutique
NZ187334A (en) Dextro isomers of asymmetric spiro-hydantoins for treatment of diabetes-associated complications
CS199690B2 (cs) Způsob výroby spiro-hydantoinových derivátů
EP0773226A1 (en) Propiophenone derivative and processes for preparing the same
IE47884B1 (en) Xanthine derivatives having antiallergic activity and pharmacological preparations containing them
CA1155123A (fr) Procedes de preparation de nouveaux derives de la piperidylbenzimidazolinone
US4312872A (en) 1-Alka-2,4-dienyl-2-hydroxymethyl-3,4,5-trihydroxypiperidines as inhibitors of α-glucoside hydrolases
US4264613A (en) Piperidylbenzimidazolinone compounds
DK155321B (da) Analogifremgangsmaade til fremstilling af 3,4,5-trihydroxypiperidinderivater
JPH09124684A (ja) プロピオフェノン誘導体およびその製法
JPS6216942B2 (en])
US4757054A (en) Pharmaceutical composition containing para-amino-benzoic acid-N-D-xyloside as an active ingredient
EP0162975A1 (en) P-alkyl or cycloalkyl phenoxy alkanols and alkanol esters and use for the treatment of allergic conditions
JPS6312063B2 (en])
EP0028923A1 (en) 1H-Benz (de) isoquinoline -2 (3H) -acetic acid derivatives, processes for their preparation, pharmaceutical compositions containing same and their use
CA1132983A (fr) Procedes de preparation de nouvelles piperazines monosubstituees
US4315921A (en) Pharmaceutical composition containing fara-amino-benzoic acid-N-D-xyloside as an active ingredient
US4380536A (en) Pharmaceutical composition containing para-amino-benzoic acid-N-D-mannoside as an active ingredient
US4611057A (en) Process for preparing pyrimidinetrione derivatives
JPS6044292B2 (ja) （ｌ）−１−（４−ヒドロキシフエノキシ）−２−ヒドロキシ−３−イソプロピルアミノ−プロパンの製法
US4322408A (en) Pharmaceutical composition containing a derivative of para-aminobenzoic acid as an active ingredient
KR950011412B1 (ko) 신규한 이소퀴놀린 화합물(들)과 이들을 함유하는 약제학적 조성물 및 그들의 제조방법
EP0204172B1 (en) Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use